Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02654587 |
|---|---|
| Brief Title: | OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure (ATALANTE-1) |
| First Submitted : | January 8, 2016 |
| First Submitted that Met QC Criteria : | January 12, 2016 |
| First Posted : | January 13, 2016 (Estimate) |
| Results First Submitted : | October 30, 2023 |
| Results First Submitted that Met QC Criteria : | January 31, 2024 |
| Results First Posted : | February 2, 2024 |
| Last Update Submitted that Met QC Criteria : | January 31, 2024 |
| Last Update Posted : | February 2, 2024 |